Regulation
J&J’s robotics and digital R&D head offers advice for device developers
Johnson & Johnson MedTech's Ottava surgical robotics system has received FDA de novo authorization. The company's Global Head of Robotics & Digital R&D shared insights on the product development process and regulatory pathway, offering guidance for other device developers navigating similar clearance challenges.
The source
This brief is a MedIndexer summary of reporting by Medical Design & Outsourcing. To read the full story, head to the source.
Read the full story at Medical Design & Outsourcing